CompaniesMedmain
Medmain logo

Medmain

active
Fukuoka, Japan
Founded 2018
Website
About

Digital Pathology

Areas of Focus

Categories

Japan
Team (9)
Atsushi Murakami
Board of Director
Medmain
board_member
Katsumasa Niki
Outside Director
Medmain
board_member
Masayuki Tsuneki
Board of Director
Medmain
board_member
Munehiro Inoue
Auditor
Medmain
team_member
Osamu Iizuka
CEO
Medmain
executive
Shigeo Nakano
Outside Director
Medmain
board_member
View all 9 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

24

By Phase

PHASE2/PHASE3: 1

By Status

UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
NCT04244006
Hover over trial bars to see details

Recent Trials

NCT04244006Collaborator
A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome
PHASE2/PHASE3Unknown
24 participants
Started: Jul 23, 2020 · Completed: Jun 1, 2024
Locations (1)
Headquarters
Fukuoka, Japan
Map

Loading map...